申请人:Hoffmann-La Roche Inc.
公开号:US07129238B2
公开(公告)日:2006-10-31
The invention is concerned with novel mandelic acid derivatives of formula (I)
wherein R1 to R10, X and Y are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof.
These compounds inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor.
本发明涉及一种新型的苯乙酸衍生物,其化学式为(I),其中R1到R10、X和Y的定义如说明书和权利要求中所述,以及其药学上可接受的盐。这些化合物可以抑制因子VIIa和组织因子诱导的凝血因子Xa、IXa和凝血酶的形成。